BACK

LFB BIOMEDICAMENTS

Specialising in plasma-derived medicinal products

LFB BIOMEDICAMENTS, a wholly-owned subsidiary of LFB SA, with its head office in Les Ulis (France), is specialised in the manufacture and the marketing of  plasma-derived medicinal products. LFB BIOMEDICAMENTS has around 1400 employees.

Executive Committee

The Executive Committee of LFB BIOMEDICAMENTS is chaired by Denis Delval (CEO), the other members being Patrick Bergeat (Operations Deputy General Manager), Philippe Grédy (Executive Vice-President, Commercial Affairs) and Robert Verdeguer (General Director, Quality and Pharmaceutical Affairs, and Head Pharmacist of LFB BIOMEDICAMENTS).

COMPOSITION OF THE LFB BIOMEDICAMENTS BOARD OF DIRECTORS

LFB-BIOMEDICAMENTS-BOARDofDIRECTORS-4dec2017